Wk 4 - Receptor and ADME Flashcards

1
Q

What is pharmacokinetics?

A

The action that the body has on the drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Pharmacodynamics?

A

The action that the drug has on the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

ADME

A

Absorption:
- Passage of drug from administration site to blood

Distribution:
- Passage of drug from blood to tissues

Metabolism/biotransformation:
- Chemical modification of drug to make more water soluble/excreted

Excretion:
- Passage of drug from blood to outside of body through urine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Passive diffusion

A
  • Driven by concentration gradient
  • Doesn’t require energy
  • Doesn’t saturate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

G-protein coupled receptors

A
  • Most common drug receptor group
  • Generate 2º messenger to change cell function
    2º messengers: cAMP, Ca++, etc…
  • Drug binds to receptor coupled to G protein which does the effector function
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What’s an orphan receptor?

A

When you don’t know what ligand the receptor binds to

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Ligand-gated ion channels

A

Mechanism:

  1. Ligand binds
  2. Channel opens
  3. ions flow through and down gradient
  4. Depolarization of membrane
  5. Generation of action potential
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Receptor direct binding/∆ gene transcription

A
  • Often associated with chaperone protein
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Filtration transport

A
  • Doesn’t require ATP
  • Bulk flow of fluids through channel
  • Driving force = osmotic pressure difference
  • Move down gradient
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Endocytosis transport

A
  • Requires ATP
  • Active bulk flow through membrane
  • Move in both directions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Facilitated diffusion

A
  • Carrier mediated
  • Doesn’t required ATP
  • Saturable
  • Selective
  • Moves down gradient
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Active transport

A
  • Requires ATP
  • Carrier mediated
  • Saturable
  • Selective
  • Moves AGAINST gradient
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What does Fick’s law describe?

A

FLUX!

FLUX = rate of transport = (permeability constant)(Cout-Cin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is bioavailability?

A

How much of a drug that’s administered to a patient is ABLE to move into circulating plasma

  • Fraction of total amount that could EVER get into circulation
  • 100% bioavailable? IV administration
  • Expressed from 0 –> 1
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What should you take away from Lipinski’s rule of 5?

A
  • A compound with good bioavailability will be relatively small and MODERATELY lipophilic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Tissue perfusion rates (distribution)

A

It’s easy to diffuse into tissues that are highly perfused with blood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Plasma binding proteins (distribution)

A

High affinity??

More plasma binding protein and LESS DISTRIBUTION

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Partitioning between plasma and tissues (distribution)

A

[ ] of drug between plasma and tissues not equal

Done via ion trapping, lipid solubilty, tissue binding protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Volume of distribution

A

Fluid volume that would be required to contain the amount of drug present in the body at the same concentration as observed in the plasma

Vd = total amount of drug given/concentration of drug in plasma

The HIGHER the concentration in the plasma the LOWER the volume of distribution

Tells us about the relative distribution of the drug in the body

… Use body weight to normalize the Vd

20
Q

Variation of Vd (lipophilic/hydrophilic drugs)

A

Vd will be lower in fat people if it’s a lipid soluble drug

21
Q

Termination: Storage/redistribution

A
  • Drug can be trapped via redistribution and stuck in places where it shouldn’t be

Ex: anesthesia example
Works with 1st and 2nd pass distribution

22
Q

Termination: excretion/elimination

A

Kidney is major player

1º function: remove excess water soluble molecules from blood and return water

Filtration (through glomerular capillaries –> pre-urine)
Reabsorption (concentration gradient in collecting tubule and diffuses back out)
Secretion (selectively pull impounds from plasma and dump them in urine)

EXCRETION = FILTRATION - REABSORPTION + SECRETION

23
Q

Renal clearance (Clr)

A

Volume of plasma that’s cleared of drug by the kidney per hour

Clr = (CuVu)/Cp

GFR = glomerular filtration rate

24
Q

Renal clearance different types

A

No reabsorption/secretion? (filtered only)
GFR = Clr = 125mL/min

Filtered and reabsorbed
Clr < GFR (less getting out)

Filtered and secreted
Clr > GFR

25
Biotransformation
In liver Purpose: make compounds more polar so they can be more water soluble and excreted in the urine - Might be required to activate a drug from prodrug to drug Phase I and II reactions often coupled but not required
26
Biotransformation phase I reactions
- Add/expose functional groups - Oxidation to make metabolites more polar/water soluble - Metabolites often become less active - MAJOR PLAYER = CYP450 - DO METABOLISM OF 75% OF DRUGS IN SER
27
Biotransformation phase II reactions
- Conjugation/synthesis reaction - Most common: glucuronidation - Usually results in inactivation - Can + large anionic groups to detoxify reactive electrophiles - SER
28
Inhibitors of biotransformation
- Inhibit CYP450 through competitive inhibition | - Non-microcosmal drug reaction like disulfiram reaction
29
Drug occupancy theory and the 2 assumptions
Relationship between drug dose and effect (using law of mass action) Assumptions: 1. Effect is proportional to the receptor occupancy 2. Interaction between drug and receptor is monovalent
30
Agonist
Drug capable of inducing maximum response Full efficacy Alpha = 1
31
Partial agonist
Drug is faction of the maximum that can be elicited overall Partial efficiacy 1 > alpha > 0
32
Antagonist
Drug can't bind receptor and induces no response Zero efficacy Alpha = 0
33
Affinity
Ability of drug to form complex with receptor 1/Kd Greater affinity of drug for receptor the lower the [ ] of drug necessary to occupy receptor
34
Efficacy
Capacity of drug/receptor complex to produce a response
35
EC50
[ ] of a drug that produces 50% of maximal response
36
Potency
COMPARATIVE TERM! - Doesn't refer to maximal response - Will always be a ratio
37
Competitive antagonism
- Reversible - SLOPE STAYS THE SAME! (max response is same) - EC50 DECREASES - Graph shifts to the right
38
Noncompetitive antagonism
- Irreversible - Max response decreased - Affinity of agonist for receptor doesn't ∆ - Apparent # of receptors decreased
39
Physiological antagonism
- Can antagonize multiple pathways Ex: insulin/glucocorticoids
40
Inverse agonist
- 2 state model theory - Does opposite of what normal agonist does - Binds inactive form to shift equilibrium to inactive form - Doesn't follow occupancy theory because not necessarily monovalent
41
Spare receptors
- Small % of receptors to elicit max response | - EC50 and Kd values different --- violation of occupancy theory
42
Describe 2 state theory
- Can be activated by agonists - Can be stopped by antagonist - Can be made inactive by inverse agonist
43
Quantal log dose-response curve
- All or nothing - Frequency distribution curve of response of population to a drug - Uses medan effective dose (ED50) = dose required to produce response in 50% of population - Helps judge drug potency
44
Therapeutic index
- Measure relative safety of a drug - Want it to be high - Ratio of LD50 -- kill 50% of population:effective for 50% of population
45
Certain safety factor
- Ratio of death of 1% of population to therapeutic dose of 99% of population